DualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing

Stock News

06/10

The biotechnology firm DUALITYBIO-B (09606) has issued a formal announcement regarding its progress towards a proposed listing.

The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.

The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1149238784"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1149238784\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1149238784?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 06:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149238784","market":"nz","top_or_hot":-1,"title":"DualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing","media":"Stock News","content":"<p>The biotechnology firm <b>DUALITYBIO-B</b> (<b>09606</b>) has issued a formal announcement regarding its progress towards a proposed listing.<br><br>The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.<br><br>The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-10 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The biotechnology firm <b>DUALITYBIO-B</b> (<b>09606</b>) has issued a formal announcement regarding its progress towards a proposed listing.<br><br>The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.<br><br>The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HK0000252160.HKD","symbol_name":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","start_time":0,"source_url":"","article_id":"1149238784","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149238784","pubTimestamp":1781044335,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The biotechnology firm DUALITYBIO-B (09606) has issued a formal announcement regarding its progress towards a proposed listing.The company is currently undergoing the preparatory guidance process for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159982":"中证500","HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","IPOS":"Renaissance International IPO ETF","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","CYB":"人民币ETF-WisdomTree Dreyfus","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","09606":"映恩生物-B","BK1161":"生物科技"},"translate_title":"DualityBio-B完成上海科创板上市的监管指导阶段","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1,"CYB":1,"IPOS":1,"MCNHmain":1,"CNHmain":1,"UCmain":1,"09606":1,"MUCmain":1},"content_text":"The biotechnology firm DUALITYBIO-B (09606) has issued a formal announcement regarding its progress towards a proposed listing.The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}